✦ LIBER ✦

Cardiovascular Preventing Effects of Dipeptidyl Peptidase-4 Inhibitors: Beyond Glucagon-Like Peptide-1

✍ Scribed by Xi-Mei Wang; Yue-Jin Yang; Yong-Jian Wu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Implications of Cardiovascular

✍ Steven G. Chrysant; George S. Chrysant 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 349 KB

Dipeptidyl peptidase-4 (DPP-4) inhibitor

✍ Sten Madsbad 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Dipeptidyl peptidase IV inhibitors in di

✍ Martin C. Michel; Eric Fliers; Cornelis J. F. Van Noorden 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 88 KB

Incretin-based treatment of type 2 diabe

✍ Carolyn F. Deacon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

The incretin system: glucagon-like pepti

✍ Daniel J Drucker; Michael A Nauck 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 320 KB

A kinetic study of glucagon-like peptide

✍ Anne-Marie Lambeir; Paul Proost; Simon Scharpé; Ingrid De Meester 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 140 KB